New nicotine pouches tested for addictiveness against cigarettes
NCT ID NCT06777784
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at whether six new nicotine oral products (pouches in flavors like cool mint and dragon fruit) are less addictive than regular cigarettes. Forty adult smokers tried each product in a controlled clinic setting. Researchers measured how much participants liked the products and how much nicotine entered their blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nicotine oral products (cool mint, smooth, wintergreen, dragon fruit flavors; 6-15 mg nicotine) and Nicorette gum
What this could lead to
If successful, this could help understand whether these nicotine products have lower abuse potential than cigarettes, potentially guiding harm reduction strategies.
What could go wrong
This is a small, completed study in 40 smokers under controlled conditions. Results may not reflect real-world use or long-term effects, and the products still contain addictive nicotine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMR Knoxville
Knoxville, Tennessee, 37920, United States
-
AMR Lexington
Lexington, Kentucky, 40509, United States